title: Molecular and therapeutic advances in the management of chronic hepatitis B and C.
abstract: Three hundred million individuals worldwide have persistent hepatitis B virus infection with 1-2 million hepatitis B virus-associated deaths per year, and an estimated 1% of the world's population are infected with hepatitis C virus. Recent advances in molecular biology and host responses have led to an increased understanding of hepatitis B and C virus disease and new potential targets for therapy.
authors.affiliation: Department of Infectious Diseases and Tropical Medicine, Brownlee Centre, Gartnavel General Hospital, Glasgow G12 8SY, UK.
authors.forename: B
authors.initials: B
authors.lastname: McCarron
authors.forename: J
authors.initials: J
authors.lastname: Main
authors.forename: H C
authors.initials: HC
authors.lastname: Thomas